Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Growblox Sciences Inc (OP: GBLX )

0.0925 USD +0.0075 (+8.82%)
Streaming Delayed Price Updated: 1:06 PM EST, Feb 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Growblox Sciences Inc

< Previous 1 2 3 4 5 6 Next >
Canadian Cannabis Legalization is Expected to Shrink U.S. Market Share
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic Pain
The nonprovisional patent applications protect formulations for pain and heart disease therapies based on myrcene-containing complex mixtures. 
From PR Newswire
North American Policies are Accelerating Cannabis Market Growth
FinancialBuzz.com News Commentary 
From PR Newswire
Data Shows Medical Cannabis Market Value is Set to Grow
From PR Newswire
Data Projects that CBD Product Sales are Expected to Grow
FinancialBuzz.com News Commentary 
From PR Newswire
Sales of Legal Cannabis Expected to Grow Domestically and Globally
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Puts Its Grey Matter To Work Solving The Big Green Riddle...
Quality and consistency of raw materials to research, manufacture and deliver trusted medical-cannabis formulations has been the single largest stumbling block for cannabis-based medical formulations... 
From GlobeNewswire News Releases
GB Sciences Will Now Serve A Greatly Expanded Patient Base In Louisiana With The Addition Of Autism, Glaucoma, Parkinson's, PTSD, Intractable Pain And Severe Muscle Spasms To The List Of Ailments Cove
GB Sciences, Inc. (OTCQB:GBLX), it all started with one woman's plea and ended with a call to action for a dramatic expansion of diseases treated by medical cannabis throughout the State of Louisiana. 
From PR Newswire
GB Sciences' Acquisition Of NevadaPURE Is Terminated
GB Sciences, Inc. (OTCQB: GBLX), the previously announced proposed acquisition of NevadaPURE, LLC, a Nevada limited liability company, by GB Sciences has been terminated. In accordance with the terms... 
From PR Newswire
CannabisNewsAudio – Global Payout, Inc. (GOHE) Prepares to Meet Rising Demand for Cannabis Payment Solutions
From CannabisNewsWire
Cannabis Market Projected to Increase in Value With Medical and Recreational Sales
FinancialBuzz.com News Commentary 
From PR Newswire
Subsidiary Industries Prepare for Growing Cannabis Market
From CannabisNewsWire
Subsidiary Industries Prepare for Growing Cannabis Market
From PR Newswire
GB Sciences is Exploring a Cannabis Therapy for Parkinson's, Analysts Review
From ACCESSWIRE
CannabisNewsAudio – Global Payout, Inc. (GOHE) Offers Cannabis Companies Unique Payment and Consulting Services
From CannabisNewsWire
Cannabis Industry Keeps Making Steps Forward
From CannabisNewsWire
Cannabis Industry Keeps Making Steps Forward
From PR Newswire
Data Projects Sales for Medical and Recreational Cannabis Products are set to Grow
FinancialBuzz.com News Commentary 
From PR Newswire
CannabisNewsAudio – Global Payout, Inc. (GOHE) Offers Alternative to Traditional Banking with Fintech Solutions
From CannabisNewsWire
GB Sciences, CEO, John Poss, Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
GB Sciences, Inc. (OTCQB:GBLX) (“the “Company”), today announced CEO, John Poss, returned to Uptick Newswire’s “Stock Day” podcast with Everett Jolly for an operational update. 
From GlobeNewswire News Releases
Budding Legal Cannabis Industry Offers Opportunity Amid Challenge, Chaos
From CannabisNewsWire
Budding Legal Cannabis Industry Offers Opportunity Amid Challenges, Chaos
From PR Newswire
Exploratory IND Is Planned Using GB Sciences' Proprietary Mixtures of Botanical Compounds to Provide the Highest Efficacy for Patients
GB Sciences, Inc. (OTCQB: GBLX), as previously reported, plans to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data, to support clinical development... 
From PR Newswire
GB Sciences Announces the Appointment of John B. Davis as Executive VP and General Counsel
GB Sciences, Inc. (OTCQB: GBLX), a company that marries cutting edge cannabis cultivation and biopharmaceutical research and development, announced today that it has appointed John B. Davis as... 
From PR Newswire
Legal and Medical Cannabis Market Sales Expected to Accelerate
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson's Disease
GB Sciences, Inc. (OTCQB: GBLX) is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies for the... 
From PR Newswire
GB Sciences Completes Nanotechnology Transfer of Exclusively-Licensed, Cannabinoid-Based, Time-Released Neuropathic Pain Formula
GB Sciences, Inc. (OTCQB: GBLX) has completed the technology transfer for the manufacturing of time-released nanoparticles containing a cannabinoid-based therapeutic for neuropathic pain from the... 
From PR Newswire
Forecast Indicates CBD Global Market Projected to Experience Continued Significant Growth
From PR Newswire
Data Projects That the Legal Cannabis Market is in Growth Mode
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Signs Letter of Intent to Acquire NevadaPURE's Las Vegas Operations: Gaining $16 Million in Annualized Revenues
GB Sciences, Inc. (OTCQB: GBLX) is extremely pleased to announce it has signed a letter of intent to purchase 100% of the ownership interests of NevadaPURE's Las Vegas operation for $28 million in cash... 
From PR Newswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.